Dr Silvia Palma | audiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Silvia Palma | audiology | Best Researcher Award  🏆

Audiologist Medical Doctor at  ausl Modena, Italy
🎓

 

Dr. Silvia Palma is an esteemed ENT medical doctor specializing in the implementation of newborn hearing screening at Ausl (Italian Public Health Agency) in Modena. She earned her PhD in Electrophysiology and Cell Biology of the Auditory System from the University of Ferrara and completed her training as an ENT specialist under the supervision of Prof. A.M. Meyer Zum Gottesberge at H. Heine University, Düsseldorf.

Silvia has made significant contributions to understanding hearing loss in children, particularly through her research on language development in those affected by congenital cytomegalovirus (cCMV) and the impact of SARS-CoV-2 on newborn auditory functions. She holds editorial positions in several prestigious journals and is an active member of the Emilia Romagna regional panel on hearing disabilities, the Italian ENT Society, and the Italian Audiological Society. Her work continues to shape advancements in pediatric audiology and hearing health.

Professional Profile 

🎓 Education

Silvia Palma obtained her PhD in Electrophysiology and Cell Biology of the Auditory System from the University of Ferrara. She trained as an ENT specialist and further developed her expertise under the guidance of Prof. A.M. Meyer Zum Gottesberge at H. Heine University, Düsseldorf.

🏢 Work Experience

Currently, Silvia serves as the responsible person for the implementation of newborn hearing screening in her county at Ausl (Italian Public Health Agency) Modena. Her work focuses on ensuring early detection of hearing impairments in infants.

🧬 Skills

Silvia possesses advanced skills in electrophysiology, audiological assessment, and research methodologies related to hearing loss in children. Her collaborative approach enhances her research impact, particularly in understanding communication development in children with hearing impairments.

🏆 Awards and Honors

She has received recognition for her contributions to audiology and pediatric health, although specific awards were not mentioned. Her editorial roles in various prestigious journals also highlight her standing in the field.

🌍 Memberships

Silvia is a member of several professional organizations, including the Emilia Romagna regional panel on hearing disabilities, the Italian ENT Society, and the Italian Audiological Society, reflecting her commitment to advancing audiology.

📚 Teaching Experience

Although specific teaching experiences weren’t detailed, her collaboration with universities suggests a role in mentoring and education in her areas of expertise, particularly in audiology and communication development.

🔬 Research Focus

Silvia’s research primarily revolves around congenital hearing loss in children, language development in children affected by congenital cytomegalovirus (cCMV), the implementation of newborn hearing screening, and audiological follow-up in children with risk factors for hearing loss. Her projects have significantly contributed to understanding the effects of SARS-CoV-2 on auditory function in newborns and evaluating communication skills in affected children.

📚 Publilcation 

  • Acute Onset of Peripheral Facial Nerve Palsy in Children: An Overview
  • Communication Skills in Toddlers Exposed to Maternal SARS-CoV-2 during Pregnancy
  • Unilateral Hearing Loss and Auditory Asymmetry in Mitochondrial Disease: A Scoping Review
  • Vestibular Rehabilitation in Adults: An Overview
    • Year: 2024
    • Journal: Hearing Balance and Communication
    • (No DOI provided)
  • Is Ehlers-Danlos Syndrome a Neglected Cause of Nosebleeds?
  • The Role of Fibrinogen, Homocysteine and Metabolic Syndrome’s Alterations in Sudden Sensorineural Hearing Loss (SSHL): A Narrative Review
  • Cochlear Implantation in Children with Additional Disabilities: A Systematic Review
  • Italian Validation of the Hearing Handicap Inventory for Elderly – Screening Version (HHIE-S-It)
  • The Effect of Alpha-Lipoic Acid in the Treatment of Chronic Subjective Tinnitus through the Tinnitus Handicap Inventory Scores
  • The Audiological Follow-Up of Children with Symptomatic Congenital Cytomegalovirus Infection: An Experience in Two Italian Centers

 

 

 

Dr Victorien Tamègnon Dougnon | Antimicrobial resistance | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Victorien Tamègnon Dougnon | Antimicrobial resistance | Best Researcher Award  🏆

Miguel Servet Researcher at  Health Research Institute of Santiago de Compostela (IDIS), Spain🎓

 

Prof. DOUGNON Tamègnon Victorien is an Associate Professor of Microbiology at the Department of Human Biology, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi (UAC), Benin. His career reflects a deep commitment to academic excellence, innovative research, and public health improvement. Prof. Dougnon is known for his significant contributions to the field of antimicrobial resistance and the valorization of African plant species. He is actively engaged in international collaborations and has played a key role in addressing major public health challenges both in Benin and across the globe. His leadership, research, and administrative roles make him a prominent figure in the scientific community.

Professional Profile 

🎓 Education

Prof. Dougnon completed his Ph.D. in Environmental and Health Sciences from the University of Abomey-Calavi in 2013. Prior to that, he earned his Master’s degree in Biomedical Sciences in 2011 and his Bachelor’s degree in the same field in 2008, all from the University of Abomey-Calavi. His educational journey laid a strong foundation for his specialization in microbiology, with a focus on addressing public health issues through scientific research.

🏢 Work Experience

Prof. Dougnon has held various academic and administrative positions throughout his career. He is the Head of the Research Unit in Applied Microbiology and Pharmacology of Natural Substances (URMAPha) at the Polytechnic School of Abomey-Calavi. In addition, he serves as the Coordinator of the Training Program for the Certificate in Hospital Hygiene and the Deputy Coordinator for the Certificate in Molecular Epidemiology of Antimicrobial Resistance and One Health Approach. He has played a critical role in organizing scientific events, capacity-building workshops, and mentoring programs to enhance the research environment at UAC.

🧬 Skills

Prof. Dougnon possesses a wide range of skills that highlight his expertise in microbiology and education. He is adept at designing and developing academic curricula, having been involved in the creation of training programs in hospital hygiene, molecular epidemiology, and medical microbiology. His skills in research methodology, data analysis, and antimicrobial resistance strategies make him a leading researcher in his field. Additionally, he excels in managing large-scale research projects, fostering international scientific collaborations, and leading resource mobilization initiatives to support research efforts.

🏆 Awards and Honors

Prof. Dougnon has received numerous awards for his contributions to science and education. In 2024, he was honored with the TWAS Regional Award for the Development of Scientific Educational Materials. In 2023, he received the Top Outstanding Young People (TOYP) Award for his leadership in education and the prestigious Francophonie Prize for Young Researchers. His work in combating sepsis earned him the Global Sepsis Award in 2022, and he was recognized as the Best Young African Researcher by the Egyptian Academy of Science and Technology in 2021. These accolades underscore his impact in both scientific research and education.

🌍 Memberships

Prof. Dougnon is an active member of several prestigious scientific organizations. He is a member of the Beninese Society of Infectious and Tropical Pathology (SOBEPIT) and the Global Young Academy. He also serves as the Country Ambassador for the American Society for Microbiology, where he previously held the role of Young Ambassador in Benin from 2016 to 2019. In addition, he is a Young Affiliate of the World Academy of Sciences (TWAS) and a member of the Academy of Young Scientists of Benin. His memberships reflect his commitment to staying engaged with the global scientific community.

📚 Teaching Experience

With over a decade of teaching experience, Prof. Dougnon has mentored numerous students at different levels of their academic careers. He teaches courses related to biomedical analysis, hygiene, sanitation, microbiology, and research methodology for undergraduate and graduate students. He has supervised over 150 undergraduate theses, 75 master’s theses, and several Ph.D. candidates, guiding them in their academic and research pursuits. His focus on nurturing future scientists and researchers highlights his dedication to education and knowledge transfer.

🔬 Research Focus

Prof. Dougnon’s research is centered on antimicrobial resistance, the valorization of African medicinal plants, and the development of phage therapy to combat multi-drug resistant bacteria. He is also actively involved in researching the effects of climate change on aquatic microbiomes and their connection to enteric diseases. His goal is to develop prevention strategies by studying the relationships between environmental and clinical microbiomes. His research not only contributes to scientific knowledge but also offers practical solutions to pressing public health challenges.

📚 Publilcation 

  • Pharmaceutical pollution of the world’s rivers
    JL Wilkinson, ABA Boxall, DW Kolpin, KMY Leung, RWS Lai, TV Dougnon, et al.
    Proceedings of the National Academy of Sciences, 2022
  • Ethnopharmacological survey on antihemorrhagic medicinal plants in South of Benin
    JR Klotoé, TV Dougnon, K Koudouvo, JM Atègbo, F Loko, A Akoègninou, et al.
    European Journal of Medicinal Plants, 2012
  • Physicochemical characteristics and microbiological quality of honey produced in Benin
    FE Azonwade, A Paraïso, CP Agbangnan Dossa, TV Dougnon, C N’tcha, et al.
    Journal of Food Quality, 2018
  • Phytochemistry and hemostatic properties of some medicinal plants sold as anti-hemorrhagic in Cotonou markets (Benin)
    C Dandjesso, JR Klotoé, TV Dougnon, J Sègbo, JM Atègbo, F Gbaguidi, et al.
    Indian Journal of Science and Technology, 2012
  • Antibacterial Activity of Chalcone and Dihydrochalcone Compounds from Uvaria chamae Roots against Multidrug‐Resistant Bacteria
    H Koudokpon, N Armstrong, TV Dougnon, L Fah, E Hounsa, HS Bankolé, et al.
    BioMed Research International, 2018
  • Toxigenic Vibrio cholerae O1 in vegetables and fish raised in wastewater irrigated fields and stabilization ponds during a non-cholera outbreak period in Morogoro
    YMG Hounmanou, RH Mdegela, TV Dougnon, OJ Mhongole, ES Mayila, et al.
    BMC Research Notes, 2016
  • Etude ethnobotanique des légumes feuilles thérapeutiques utilisés dans le traitement des diarrhées au sud-Bénin (Afrique de l’Ouest)
    AJ Agbankpé, TV Dougnon, HS Bankolé, B Yèhouénou, H Yédomonhan, et al.
    International Journal of Biological and Chemical Sciences, 2014
  • Haematological evaluation of Wistar rats exposed to chronic doses of cadmium, mercury and combined cadmium and mercury
    ASY Hounkpatin, PA Edorh, P Guédénon, CG Alimba, A Ogunkanmi, TV Dougnon, et al.
    African Journal of Biotechnology, 2013

 

 

 

 

 

Dr Rojarani Pallavali | Microbiology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr Rojarani Pallavali | Microbiology | Women Researcher Award 🏆

Senior Solution Leader at Brane enterprises pvt ltd,India🎓

 

Dr. Pallavali Roja Rani, Ph.D. is a dedicated microbiologist with a robust focus on antimicrobial resistance, microbial biofilms, and biotechnological applications. Her work delves into understanding how microorganisms develop resistance to antibiotics, the role of biofilms in infections, and the use of CRISPR-Cas technology to explore resistance mechanisms. Additionally, Dr. Rani is passionate about environmental biotechnology, microbial symbiosis, and the human gut microbiome.

Professional Profile 

🎓 Education

Dr. Rani earned her Ph.D. in Microbiology from Yogi Vemana University, India, in 2019. Her research focused on the isolation and characterization of bacteriophages against multi-drug resistant (MDR) bacteria, aiming to explore biological control mechanisms. She also holds a Master’s degree in Virology and a Bachelor’s degree in Biochemistry, Microbiology, and Chemistry, both from Sri Venkateswara University, Tirupathi.

🏢 Work Experience

Dr. Rani is currently a Senior Research Scientist at Brane Enterprises Pvt Ltd, Hyderabad, India, leading projects on the 3D representation of the human brain and microbial genomics within the Human Genome Project. Previously, she served as a Post-Doctoral Scientist at the Korean National University of Transportation and managed molecular diagnostics at the State COVID Hospital in India, where she oversaw over 15 million RT-PCR tests. She also has experience teaching microbiology at various universities and worked in molecular microbiology research labs.

🧬 Skills

Dr. Rani has extensive skills in molecular microbiology, including antimicrobial resistance mechanisms, bacteriophage therapy, biofilm disruption, microbial ecology, and gene cloning. She is proficient in advanced microbiological techniques such as RT-PCR, Next-Generation Sequencing (NGS), ELISA, and Western blotting. Additionally, she has hands-on experience with bioinformatics tools, statistical analysis (GraphPad Prism), and data visualization.

🏆 Awards and Honors

Throughout her career, Dr. Rani has been recognized for her outstanding contributions. She was awarded a Junior Research Fellowship from the Council of Scientific and Industrial Research (CSIR) and the prestigious Best Employee Award in 2021 for her leadership during the COVID-19 pandemic.

📚 Teaching Experience

With over a decade of teaching experience, Dr. Rani has mentored both undergraduate and graduate students in microbiology and biotechnology. She has also supervised large teams in laboratory settings, particularly during the pandemic, leading over 50 personnel in molecular diagnostics and research.

🔬 Research Focus

Her research centers on antibiotic resistance, microbial biofilms, phage therapy, and CRISPR-Cas applications in microbiology. She is particularly interested in microbial symbiosis, the role of microbiomes in health and disease, and the environmental applications of microbial communities in sustainable practices.

📚 Publications 

  • High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing
    RC Bhoyar, A Jain, P Sehgal, MK Divakar, D Sharma, M Imran, B Jolly, RR Pallavali, et al.
    PloS One, 2021
  • Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections
    RR Pallavali, VL Degati, D Lomada, MC Reddy, VRP Durbaka
    PloS One, 2017
  • Green synthesis of silver nanoparticles and evaluation of their antibacterial activity against multidrug-resistant bacteria and wound healing efficacy using a murine model
    V Lakkim, MC Reddy, RR Pallavali, KR Reddy, CV Reddy, Inamuddin, et al.
    Antibiotics, 2020
  • Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape
    PR Rani, M Imran, JV Lakshmi, B Jolly, A Jain, et al.
    Journal of Medical Virology, 2021
  • Data of antibacterial activity of plant leaves crude extract on bacterial isolates of wound infections
    RR Pallavali, S Avula, VL Degati, M Penubala, AG Damu, VRP Durbaka
    Data in Brief, 2019
  • Lytic bacteriophages against bacterial biofilms formed by multidrug-resistant Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus
    RR Pallavali, VL Degati, VR Narala, KK Velpula, S Yenugu, VRP Durbaka
    Therapy, Applications, and Research, 2021
  • Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes
    B Jolly, M Rophina, A Shamnath, M Imran, RC Bhoyar, MK Divakar, RR Pallavali, et al.
    BioRxiv, 2020

 

 

 

 

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr NISHI PATEL | Neuroscience | Best Researcher Award   🏆

Research Scholar at Bhagwan Mahavir University, Surat , India🎓

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease 🧠. With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinson’s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional Profile 

  • Google Scholar 

Education 🎓

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience 🏢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors 🏆

While specific awards are not mentioned, Dr. Patel’s numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus 🔍

Dr. Patel’s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinson’s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications : 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum – An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinson’s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Mr Di Wu | Problem Solving | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr Di Wu | Problem Solving | Best Researcher Award 🏆


MD/PhD Candidate at  Saint Louis University School of Medicine,United States🎓

Di (Andy) Wu is a doctoral candidate in Molecular Microbiology and Immunology at Saint Louis University School of Medicine, expected to earn his Ph.D. in Fall 2024. He also pursues his M.D. with an expected graduation in Spring 2027. Wu holds a B.S. in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign, where he graduated Summa Cum Laude. His research interests include osteoimmunology, T cell biology, and systems biology, with significant contributions to understanding bone quality and immune responses in osteoporosis. Wu has published several notable papers and has presented his research at multiple conferences. As an active mentor and leader in the American Physician Scientists Association, he is dedicated to fostering the next generation of scientists. Wu also engages in community service, facilitating support groups for families affected by mental health issues through the National Alliance on Mental Illness (NAMI). His commitment to research and community makes him a promising figure in the biomedical sciences.

Professional Profile 

Education 🎓

Di (Andy) Wu is currently a doctoral candidate in Molecular Microbiology and Immunology at Saint Louis University School of Medicine, expecting to complete his Ph.D. in Fall 2024. He is also pursuing his Doctor of Medicine (MD) degree at the same institution, which he expects to receive in Spring 2027. Andy earned his Bachelor of Science in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign in May 2017, where he graduated with high honors.

Work Experience 🏢

Andy has extensive research experience, serving as a Doctoral Candidate in the Department of Molecular Microbiology and Immunology at Saint Louis University since 2019. He has conducted significant research on the effects of estrogen loss on bone fragility and the therapeutic potential of pulsed RANKL in osteoporosis. Prior to this, he was a Summer Medical Student Research Assistant in 2018, where he worked with infectious agents, specifically the Rift Valley Fever Virus, and tested compounds for their efficacy against the virus. His undergraduate research at the University of Illinois involved studying the defense mechanisms of Salmonella Typhimurium against oxidative stress.

Skills 🔬

Andy possesses a strong background in molecular microbiology and immunology, with specific expertise in T cell biology, osteoimmunology, and systems biology. He has developed technical skills in handling BSL3 infectious agents, conducting in vitro experiments, and utilizing various research methodologies to investigate complex biological questions. His mentoring and leadership skills are demonstrated through his roles in various academic organizations.

Awards and Honors 🏆

Throughout his academic career, Andy has received several prestigious awards, including graduating Summa Cum Laude from the University of Illinois, recognition on the Bronze Tablet for ranking in the top 3% of his graduating class, and achieving the Highest Distinction in Research and Academia for his senior thesis. These honors reflect his commitment to academic excellence and research contributions.

Membership 🌍

Andy is an active member of several professional organizations, including the American Physician Scientists Association (APSA), the Asian Pacific American Medical Student Association (APAMSA), and the American Society for Microbiology (ASM). His involvement in these groups showcases his dedication to the scientific community and his interest in promoting collaboration among peers.

Teaching Experience 👨‍🏫

As a Graduate Research Assistant, Andy has mentored undergraduate and medical students in their summer research internships, providing guidance and support in their scientific endeavors. Additionally, he serves as a peer mentor for students considering careers in medicine and science, sharing his experiences to help them navigate their educational paths.

Research Focus 🔍

Andy Wu’s research interests center on osteoimmunology, T cell biology, and bone quality, with a particular focus on understanding the mechanisms underlying bone fragility and postmenopausal osteoporosis. His work aims to explore the interplay between immune responses and bone health, contributing to the development of potential therapeutic strategies for bone-related diseases.

Publications : 

  • Memory T-Cells Contribute to Calcium Release from Bones during Lactation in Mice
    Year: 2024
    Journal: Nutrients
    DOI: 10.3390/nu16193289
  • T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
    Year: 2021
    Journal: Frontiers in Immunology
    DOI: 10.3389/fimmu.2021.687551

 

Dr Alexander Chernov| neuro-oncology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr Alexander Chernov| neuro-oncology | Best Researcher Award 🏆


DR at Institute of Experimental Medicine🎓

Dr. Alexander Nikolaevich Chernov is a PhD and Senior Researcher at the World-Class Research Centre “Center for Personalized Medicine” at the Institute of Experimental Medicine, Saint Petersburg, Russia 🧬. With an impressive portfolio of over 80 scientific papers, six patents, and ongoing collaborations with international institutions, Dr. Chernov has made significant contributions in the fields of neuroimmunooncology, glioblastoma research, and the study of nerve growth factors. In 2021, he defended his PhD thesis on the effects of nerve growth factor and immune peptides on brain tumor cells, and in 2022-2023, he completed a postdoctoral fellowship at Ben-Gurion University, Israel 🇮🇱.

 

Professional Profile 

Education 🎓

Dr. Chernov holds a PhD with expertise in neurobiology, focusing on brain tumors and chemotherapy. He has a solid foundation in biochemistry, serving as an assistant professor at Saint Petersburg State Pediatric Medical University 🎓.

Work Experience 🏢

Dr. Chernov’s extensive research includes working as a senior researcher at multiple prestigious institutions in Russia, including the D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. He has also been involved in numerous consultancy and industry projects across nine different sectors.

Awards and Honors 🏆

Dr. Chernov has earned recognition for his exceptional work in brain tumor research, including the nomination for the Best Researcher Award for his article on glioblastoma sensitivity to antimicrobial peptides.

👨‍🏫 Teaching & Memberships🌍

Dr. Chernov is a dedicated educator, currently teaching biochemistry at Saint Petersburg State Pediatric Medical University. He is a member of the Belarusian Society of Physiologists, contributing to his international scientific community .

Research Focus 🔍

His main research areas include glioblastoma, nerve growth factors, chemotherapy, and antimicrobial peptides such as LL-37 and PG-1 🧠. Dr. Chernov’s groundbreaking work has shown how these peptides, in combination with chemotherapy drugs, can predict overall survival in patients with glioblastoma. His research has also demonstrated the effects of these combinations on the inhibition of glioma cell clonogenicity and migration.

Publications : 

 

  • “Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors”
    • Medicinal Chemistry, 2012
  • “Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier”
    • Pharmaceutics, 2011
  • “Biological activity of silver-doped DLC films”
    • Diamond and Related Materials, 2009
  • “Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome”
    • Frontiers in Genetics, 2020
  • “Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients”
    • Frontiers in Immunology, 2021
  • “The phenomenon of multidrug resistance in glioblastomas”
    • Hematology/Oncology and Stem Cell Therapy, 2021
  • “Genetic risk factors for the development of COVID-19 coronavirus infection”
    • Russian Journal of Genetics, 2021
  • “Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients”
    • Pharmaceutics, 2022
  • “Pathophysiological mechanisms of autism in children”
    • Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020
  • “Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration”
    • Molecules, 2022

Prof Dr Leidy Azucena Ramírez Fráncel | functional ecology | Best Researcher Award

Published on by Cognitive Scientist Awards

 Prof Dr Leidy Azucena Ramírez Fráncel | functional ecology | Best Researcher Award 🏆


Academician/Research Scholar at  Professor and researcher🎓

Leidy Azucena Ramírez-Fráncel is a distinguished biologist from Colombia, with expertise in the study of insectivorous bats. She holds a PhD in Biological Sciences and currently serves as a professor and researcher at the University of Ibagué. As a Minciencias Fellow, her work significantly contributes to the conservation of tropical dry forests, focusing on the ecological role of bats in pest control.

Professional Profile 

Education 🎓

Leidy holds a Bachelor’s degree in Natural Sciences, a Master’s, and a PhD in Biological Sciences, all from the University of Tolima. Her doctoral thesis was recognized for its excellence, particularly in its examination of ecomorphological traits of bats.

Work Experience 🏢

She is a postdoctoral researcher and professor at the University of Ibagué. Leidy’s professional journey includes significant contributions to understanding bat ecology, particularly how their cranial morphology and bite force allow them to adapt to different prey in tropical ecosystems.

Skills 🔬

Her skill set includes expertise in ecomorphology, field research, biological control, ecological conservation, and statistical analysis related to biodiversity. She is also proficient in scientific writing and publishing.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Leidy is associated with several scientific communities, contributing her expertise in biological sciences and conservation efforts. She actively collaborates with Minciencias, a prestigious Colombian research network.

Teaching Experience 👨‍🏫

As a professor at the University of Ibagué, Leidy teaches courses in biological sciences, guiding students in topics like biodiversity, ecology, and conservation. Her hands-on teaching style incorporates fieldwork, mentoring young researchers, and promoting sustainable conservation practices.

Research Focus 🔍

Her research primarily revolves around the cranial morphology, bite force, and diet of insectivorous bats from the Colombian tropical dry forest. Leidy has published extensively on how these traits allow bats to feed on prey of varying hardness, emphasizing their role in pest control and their ecological importance in maintaining the balance of vulnerable ecosystems.

 

 

Publications : 

  • Bats and their vital ecosystem services: a global review
    2022 – Integrative Zoology, 17(1), 2-23
  • Mamíferos en relictos de bosque seco tropical del Tolima, Colombia
    2015 – Mastozoología Neotropical, 22(1), 11-21
  • Mamíferos del departamento del Tolima: distribución y estado de conservación
    2019 – Revista UDCA Actualidad & Divulgación Científica, 22(2)
  • Foraging strategies, craniodental traits, and interaction in the bite force of Neotropical frugivorous bats (Phyllostomidae: Stenodermatinae)
    2021 – Ecology and Evolution, 11(20), 13756-13772
  • Using MaxEnt modeling to predict the potential distribution of Platyrrhinus ismaeli (Phyllostomidae)
    2020 – Therya, 11(2), 203-212
  • Human-bat interactions in central Colombia: regional perceptions of a worldwide fragile life zone
    2021 – Ethnobiology and Conservation, 10, 1-18
  • Consumo de plantas pioneras por murciélagos frugívoros en un fragmento de bosque seco tropical (Colombia)
    2019 – Ciencia en Desarrollo, 10(2), 33-41
  • Bats and their vital ecosystem services: a global review
    2022 – Integrative Zoology, 17(1), 2-23
  • Skull morphology, bite force, and diet in insectivorous bats from tropical dry forests in Colombia
    2021 – Biology, 10(10), 1012
  • Potential distribution of Sphaeronycteris toxophyllum in Colombia and new record
    2018 – Therya, 9(3), 255-260

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award 🏆

Chief Researcher at The Scientific and Technological Research Council (TUBITAK), Marmara Research Center (MAM)🎓

Dr. Yüksel Çetin is the Chief Researcher at the Life Sciences, Medical Biotechnology Unit of TUBITAK’s Marmara Research Centre, Turkey. He earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, with a minor in Toxicology. His postdoctoral work focused on pulmonary disease pathogenesis through the FP 6 PULMONET project. Yüksel specializes in in vivo and in vitro toxicology, studying novel drugs, biomaterials, and nanoparticles. He leads several funded projects, including NANOBIO4CAN for cancer therapies and the development of 3D cardiac patches. His commitment to innovation and safety in biotechnology highlights his significant contributions to the field.

 

Professional Profile 

Education 🎓

Yüksel Çetin earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, USA, with a minor in Toxicology from the Toxicology Centre for Environmental Toxicology at the Eppley Institute for Research in Cancer and Allied Diseases. His postdoctoral research focused on the pathogenesis of pulmonary disease through the FP 6 PULMONET Marie Curie Project at the European Commission’s Joint Research Centre.

Work Experience 🏢

Currently serving as Chief Researcher at the Life Sciences, Medical Biotechnology Unit of the Scientific & Technological Research Council of Turkey (TUBITAK) at the Marmara Research Centre, Yüksel has held multiple leadership roles in various research projects, overseeing significant budgets and collaborative efforts aimed at advancing medical biotechnology and toxicology.

Skills 🔬

Yüksel possesses extensive expertise in in vivo and in vitro toxicology, molecular mechanisms of drugs, biomaterials, and medical devices. His proficiency in three-dimensional bioprinting technology and nanoparticle research is complemented by a robust background in evaluating the pathogenicity of xenobiotics.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Yüksel is an active member of various scientific organizations and advisory boards, including involvement in Horizon 2020 projects focused on nanotechnology and safety assessments, emphasizing his commitment to advancing scientific research and innovation.

Teaching Experience 👨‍🏫

With a wealth of knowledge, Yüksel has shared his expertise through teaching roles at various academic institutions, focusing on topics related to food science, toxicology, and medical biotechnology, mentoring the next generation of scientists.

Research Focus 🔍

His research primarily investigates the toxicological effects of novel drugs, biomaterials, and nanoparticles, as well as the development of innovative therapeutic approaches for cancer treatment. Yüksel’s projects encompass antiviral research, tissue regeneration, and vaccine development, demonstrating his dedication to impactful scientific advancements.

 

Publications : 

  • Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay
    Year: 2005
    Journal: Food and Chemical Toxicology
  • In vitro evaluation of the toxicity induced by nickel soluble and particulate forms in human airway epithelial cells
    Year: 2011
    Journal: Toxicology in vitro
  • Evaluation of reduced toxicity of zearalenone by extrusion processing as measured by the MTT cell proliferation assay
    Year: 2005
    Journal: Journal of Agricultural and Food Chemistry
  • Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells
    Year: 2009
    Journal: Cellular Physiology and Biochemistry
  • Evaluation of the molecular mechanisms of a palladium (II) saccharinate complex with terpyridine as an anticancer agent
    Year: 2014
    Journal: Anti-Cancer Drugs
  • A novel system to study the impact of epithelial barriers on cellular metabolism
    Year: 2000
    Journal: Annals of Biomedical Engineering
  • Confirmation of reduced toxicity of deoxynivalenol in extrusion-processed corn grits by the MTT bioassay
    Year: 2006
    Journal: Journal of Agricultural and Food Chemistry
  • The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
    Year: 2022
    Journal: Molecular Therapy
  • The Development of Novel Approaches to the Identification of Chemical and Protein Respiratory Allergens: Progress made from the Conclusions and Recommendations of ECVAM Workshop 60
    Year: 2008
    Journal: Alternatives to Laboratory Animals
  • Fabrication of a dual-drug-loaded smart niosome-g-chitosan polymeric platform for lung cancer treatment
    Year: 2023
    Journal: Polymers
  • Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity
    Year: 2022
    Journal: Phytochemical Analysis
  • A palladium (II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model
    Year: 2017
    Journal: Anti-Cancer Drugs

Prof Dr ALI Al KAISSI | Congenital Bone disorders | Excellence in Research

Published on by Cognitive Scientist Awards

 Prof Dr ALI Al KAISSI | Congenital Bone disorders | Excellence in Research 🏆

Honorary Prof at Ilizarov Institute, National Medical Re, Austria🎓

Dr. Ali Al Kaissi is an accomplished medical professional and researcher, known for his extensive work in pediatric orthopedics and genetic syndromes. Born in Baghdad, Iraq, Dr. Al Kaissi currently holds Austrian and Iraqi citizenship. He serves as a Visiting Professor at the National Medical Research Center for Traumatology and Orthopedics, Ilizarov, in Kurgan, Russia. His career spans decades of clinical and academic expertise, with numerous international collaborations and contributions to the medical field.

 

Professional Profile 

🎓 Education

Dr. Al Kaissi holds a Doctor of Medicine and Science (DSc – Honorary) from the Turner Scientific Research Institute, Russia (2017). He earned an MSc in Pediatric Developmental Abnormalities from the University of Warwick, UK (1988-1990) and completed his MD at the Faculty of Medicine, Azhar University, Cairo, Egypt (1972-1978). He also obtained a Certificate in Pediatrics from the University of Warwick, UK (1987-1988).

💼 Work Experience

Dr. Al Kaissi has served as a Consultant and Scientist at the Pediatric Department of the Orthopedic Hospital of Speising in Vienna, Austria, since 2005. He was also a Consultant at the Ludwig-Boltzmann Institute of Osteology, Vienna (2005-2021). Prior to that, he worked as a Consultant and Clinical Researcher at the Department of Pediatric Orthopedics at the Children’s Hospital in Tunis, Tunisia (1993-2005), and held various roles as Resident and Senior House Officer in Baghdad, Iraq (1980-1986).

🏆 Awards and Honors

He was awarded an Honorary Doctorate from the Pediatric Orthopedic Institute in Saint Petersburg, Russia (2017) and received the prestigious Russian Golden Medal for Distinguished Clinicians the same year. In 2019, he was honored with the Silver Dagistani Sword for Distinguished Clinicians and Researchers.

🔬 Research Focus

Dr. Al Kaissi’s research has led to groundbreaking discoveries, including the identification of Al Kaissi Syndrome (OMIM 617694). He has contributed significantly to the research on 3MC syndrome and Desbuquois dysplasia. His primary focus lies in pediatric musculoskeletal disorders, skeletal dysplasia, and genetic malformations, with numerous publications in the field of medical genetics.

📜 Teaching Experience

He has been an Honorary Professor at the Pediatric Orthopedic Institute in Saint Petersburg, Russia, since 2010 and a Visiting Professor at the National Medical Research Center for Traumatology and Orthopedics, Ilizarov, Kurgan, Russia, since 2020.

🌍 Memberships

Dr. Al Kaissi is a member of the Royal Society of Medicine (UK), the Austrian Medical Council, the Tunisian Medical Association, and the Science Advisory Board (USA).

📚 International Collaborations

Dr. Al Kaissi maintains extensive collaborations with institutions in Russia, the UK, Canada, and Australia. He has co-authored numerous papers with Prof. Michael Baraitser (UK) and Prof. Kazimierz Kozlowski (Australia), focusing on genetic disorders and pediatric orthopedics.

 

Publications : 

  • The Orthopedic Strategy for Patients with Larsen Syndrome
    Year: 2024
    Journal: Preprint
    DOI: 10.20944/preprints202407.2467.v1
  • Radiographic and Tomographic Study of the Cranial Bones in Children with the Idiopathic Type of West Syndrome
    Year: 2024
    Journal: Pediatric Reports
    DOI: 10.3390/pediatric16020035
  • Radiographic and Tomographic Study of the Cranial Bones in Children with the Idiopathic Type of West Syndrome
    Year: 2023
    Journal: Preprint
    DOI: 10.20944/preprints202312.0512.v1
  • Cutaneous, Cranial, and Skeletal Defects in Children and Adults with Focal Dermal Hypoplasia
    Year: 2023
    Journal: Children
    DOI: 10.3390/children10101715
  • Meticulous and Early Understanding of Congenital Cranial Defects Can Save Lives
    Year: 2023
    Journal: Children
    DOI: 10.3390/children10071240
  • The Tomographic Study and the Phenotype of Wormian Bones
    Year: 2023
    Journal: Diagnostics
    DOI: 10.3390/diagnostics13050874
  • Craniofacial Malformations as Fundamental Diagnostic Tools in Syndromic Entities
    Year: 2022
    Journal: Diagnostics
    DOI: 10.3390/diagnostics12102375
  • Infantile Systemic Hyalinosis: Variable Grades of Severity
    Year: 2021
    Journal: African Journal of Paediatric Surgery (AJPS)
    PMID: 34341308 | DOI: 10.4103/ajps.ajps_162_20
  • Upper Limb Pathology in Children with Mucopolysaccharidoses
    Year: 2021
    Journal: Traumatology and Orthopedics of Russia
    DOI: 10.21823/2311-2905-2021-27-2-34-43
  • Clinical Phenotype and Bone Biopsy Characteristics in a Child with Proteus Syndrome
    Year: 2021
    Journal: Calcified Tissue International
    PMID: 34003338 | DOI: 10.1007/s00223-021-00862-z

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences